Formic Acid

Formic Acid

SCHEMBL388257

CC(C)NC(C)C.O=CO

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.57
ADH1B P00325 2/20 0.42
ADH1C P00326 2/20 0.42
ADH1A P07327 2/20 0.42
TSHR P16473 1/20 0.33
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL30690224 0.79
SCHEMBL29066514 0.79 TDP1 (0.57) TDP1ADH1BADH1CADH1A
Methyl Alcohol SCHEMBL2170375 0.76
Isobutane SCHEMBL29090726 0.76 ADH1B (0.35) ADH1BADH1CADH1ATSHRALDH1A1
Hydrogen Peroxide SCHEMBL135019 0.76
Hydrogen Peroxide SCHEMBL135017 0.76 TDP1 (0.80) TDP1ALDH1A1GAA
Isobutane SCHEMBL29280324 0.76 ADH1B (0.35) ADH1BADH1CADH1ATSHRALDH1A1
Formic Acid SCHEMBL1836111 0.76 ADH1B (0.33) ADH1BADH1CADH1AALDH1A1
SCHEMBL2020 0.76
SCHEMBL1332279 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113214110-A Preparation method of alpha-substituted-beta-hydroxy nitrile compound and derivative thereof 南方科技大学 2021-08-06 CN claimed
EP-2265617-B1 SOLVENTS BIONIQS LTD (GB) 2014-07-02 EP claimed
EP-2265617-A1 SOLVENTS Bioniqs Limited (GB) 2010-12-29 EP claimed
WO-2009034329-A1 SOLVENTS BIONIQS LIMITED (GB) 2009-03-19 WO claimed
CN-116478046-B Method for preparing tertiary amine by taking secondary amine as raw material 浙江新化化工股份有限公司 2025-03-07 CN disclosed
US-20240228449-A1 METHOD FOR PREPARING TERTIARY AMINE WITH SECONDARY AMINE AS RAW MATERIAL ZHEJIANG XINHUA CHEMICAL CO., LTD (CN) 2024-07-11 US disclosed
EP-4324820-A1 METHOD FOR PREPARING TERTIARY AMINE BY USING SECONDARY AMINE AS RAW MATERIAL Zhejiang Xinhua Chemical Co., Ltd. (CN) 2024-02-21 EP disclosed
CN-116606212-A Method for economically and continuously preparing tertiary amine 浙江新化化工股份有限公司 2023-08-18 CN disclosed
CN-116478046-A Method for preparing tertiary amine by taking secondary amine as raw material 浙江新化化工股份有限公司 2023-07-25 CN disclosed
WO-2023134439-A1 METHOD FOR PREPARING TERTIARY AMINE BY USING SECONDARY AMINE AS RAW MATERIAL 浙江新化化工股份有限公司 2023-07-20 WO disclosed
CN-113214110-B Preparation method of alpha-substituted-beta-hydroxy nitrile compound and derivative thereof 南方科技大学 2022-07-29 CN disclosed
CN-113214110-A Preparation method of alpha-substituted-beta-hydroxy nitrile compound and derivative thereof 南方科技大学 2021-08-06 CN disclosed
EP-1740947-A2 FLUORESCENT DYES AND COMPLEXES CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) 2007-01-10 EP disclosed
CN-1761673-A guanidine derivatives and their use as neuropeptide FF receptor antagonists ACTELION PHARMACEUTICALS LTD (CH) 2006-04-19 CN disclosed
WO-2005098437-A2 FLUORESCENT DYES AND COMPLEXES CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LTD (GB) 2005-10-20 WO disclosed
EP-0238061-B1 CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS Banyu Pharmaceutical Co., Ltd. (JP) 1992-10-21 EP disclosed
US-4988687-A Thiazoleoxyimineacetamido carboxymethylpyridinium derivatives of cephalosporins BANYU PHARMACEUTICAL COMPANY, LTD. (JP) 1991-01-29 US disclosed
US-4880797-A THIAZOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-11-14 US disclosed
EP-0238061-A2 Cephalosporin derivatives, processes for their preparation and antibacterial agents Banyu Pharmaceutical Co., Ltd. (JP) 1987-09-23 EP disclosed
US-4454567-A Electrolytic capacitor containing a mixed solvent system SPRAGUE ELECTRIC COMPANY (US) 1984-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228449-A1 METHOD FOR PREPARING TERTIARY AMINE WITH SECONDARY AMINE AS RAW MATERIAL OTC, AOC1, ODC1 TDP1 729/4885ADH1B 297/4885ADH1C 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.